Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (32)

Company Market Cap Price
MRK Merck & Co., Inc.
Animal Health is a defined segment contributing to Merck's diversified revenue base.
$218.54B
$86.08
-1.09%
ZTS Zoetis Inc.
Zoetis operates across both companion animal and livestock health, aligning with Animal Health & Nutrition as a core business.
$64.74B
$144.25
-0.80%
CL Colgate-Palmolive Company
Hill's Pet Nutrition contributes to animal health and nutrition, an investable theme.
$62.52B
$75.73
-1.83%
ADM Archer-Daniels-Midland Company
Nutrition segment includes Animal Nutrition, aligning with the Animal Health & Nutrition investable theme.
$29.49B
$60.48
-1.44%
TSCO Tractor Supply Company
Acquisition of Allivet and pet-health related offerings expand animal health and nutrition categories.
$29.42B
$54.23
-2.26%
CHWY Chewy, Inc.
Chewy sells pet medications and animal health products via Chewy Health, aligning with animal health and nutrition.
$14.18B
$33.68
-1.41%
BG Bunge Global S.A.
BG's production of oilseed meals and other feed ingredients positions it in animal nutrition.
$12.95B
$96.13
-0.25%
ELAN Elanco Animal Health Incorporated
Elanco's core product line comprises animal health & nutrition products for both pets and farm animals.
$10.99B
$22.60
+2.17%
DAR Darling Ingredients Inc.
Core operations produce animal-based feed ingredients and nutrition products derived from rendered by-products.
$5.35B
$33.55
-0.75%
BCPC Balchem Corporation
Balchem's Animal Nutrition & Health segment provides chelated minerals and other feed additives that improve animal nutrition and productivity, aligning with Animal Health & Nutrition.
$5.04B
$153.80
-0.87%
FRPT Freshpet, Inc.
Freshpet's core offerings are animal nutrition and pet foods produced for dogs and cats, aligning with Animal Health & Nutrition.
$2.63B
$52.66
-2.15%
CENT Central Garden & Pet Company
CENT's product focus on animal nutrition and pet consumables aligns with the Animal Health & Nutrition investable theme.
$2.06B
$31.07
-4.16%
PAHC Phibro Animal Health Corporation
Core business is Animal Health and Nutrition, including MFA, vaccines, and related products.
$1.69B
$40.90
-1.87%
SPB Spectrum Brands Holdings, Inc.
Animal health & nutrition; Spectrum Brands’ pet nutrition offerings align with animal health and nutrition investable themes.
$1.41B
$54.78
-2.79%
NEOG Neogen Corporation
Animal Health & Nutrition captures Neogen's veterinary pharmaceuticals and animal health product offerings.
$1.34B
$6.24
+1.22%
REX REX American Resources Corporation
Dried distillers grains (DDGs) and MDGs are by-products sold as animal nutrition/feed ingredients.
$1.05B
$31.77
-0.64%
WOOF Petco Health and Wellness Company, Inc.
Animal health and nutrition products form part of the offering.
$873.13M
$3.49
-3.59%
ODC Oil-Dri Corporation of America
Animal Health Nutrition segment uses minerals as carriers and functional ingredients.
$828.38M
$54.82
-3.13%
BFLY Butterfly Network, Inc.
Veterinary imaging and animal-health application of Butterfly's ultrasound technology.
$546.51M
$2.17
-2.04%
OSUR OraSure Technologies, Inc.
SMS segment includes animal health sample collection/diagnostics, extending OraSure's reach into animal health testing.
$214.68M
$2.79
-2.61%
BARK BARK, Inc.
Animal Health & Nutrition covers pet kibble, toppers, supplements and dental care products Bark sells.
$143.57M
$0.84
-0.68%
VANI Vivani Medical, Inc.
OKV-119 for companion animals expands the portfolio into Animal Health & Nutrition.
$98.94M
$1.72
+2.99%
ICCC ImmuCell Corporation
ImmuCell directly manufactures animal health products (First Defense colostrum-based products and Re-Tain mastitis therapy) for dairy and beef cattle.
$55.67M
$6.08
-1.38%
OSTX OS Therapies Incorporated
OS Animal Health subsidiary commercializes OST-HER2 for canine osteosarcoma, an animal health/oncology effort.
$52.54M
$1.86
-0.27%
COOT Australian Oilseeds Holdings Limited Ordinary Shares
High-protein meal byproduct is used as animal feed/nutrition, corresponding to Animal Nutrition.
$49.10M
$1.40
-20.45%
ZIVO ZIVO Bioscience, Inc.
Directly related to animal health and nutrition via proprietary algal bioactive ingredients and potential applications in poultry and other animals.
$29.61M
$13.33
AIMD Ainos, Inc.
VELDONA pet supplements and veterinary applications place AIMD in Animal Health & Nutrition.
$15.03M
$3.65
+0.83%
GELS Gelteq Limited Ordinary Shares
The company's activities include animal health & nutrition initiatives and animal drug development efforts, aligning with Animal Health & Nutrition.
$9.90M
$1.20
-1.64%
SNOA Sonoma Pharmaceuticals, Inc.
Animal wound and skin care HOCl products distributed through animal health channels.
$6.29M
$3.81
-0.65%
JAGX Jaguar Health, Inc.
Jaguar Animal Health markets Canalevia and other animal health products, placing it in the Animal Health & Nutrition category.
$2.10M
$2.04
-0.97%
TWG Top Wealth Group Holding Limited Ordinary Shares
Strategic MOU signals a planned diversification into animal health and nutrition/pharma products, aligning with the Animal Health & Nutrition investable theme.
$1.76M
$5.38
-1.47%
CDT CDT Equity Inc.
Manoira joint development for animal health indicates an animal health/nutrition portfolio.
$307011
$2.96
-4.06%

Loading research report...

BARK BARK, Inc.

BARK Launches Subscriber Perks Program Offering Up to $1,500 in Annual Value

Oct 28, 2025
ELAN Elanco Animal Health Incorporated

Elanco Expands Credelio Quattro and Credelio Labels to Include Lyme Disease Prevention and Longhorned Tick Protection

Oct 27, 2025
ZTS Zoetis Inc.

Zoetis Secures Health Canada Approval for Lenivia, First Long‑Acting OA Pain Therapy in Dogs

Oct 15, 2025
SNOA Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals Registers Manufacturing Facility and Facial Spray Under FDA MoCRA

Oct 07, 2025
FRPT Freshpet, Inc.

Freshpet Names Ivan Garcia as Interim CFO Amid Todd Cunfer Departure

Oct 07, 2025
ZTS Zoetis Inc.

Zoetis Receives Positive EU Regulatory Opinion for Portela® Cat OA Pain Therapy

Sep 12, 2025
ZTS Zoetis Inc.

Zoetis Secures New Five-Year $1.25 Billion Revolving Credit Facility

Aug 27, 2025
ZTS Zoetis Inc.

Zoetis Prices $1.85 Billion in Senior Notes for Debt Repayment

Aug 11, 2025
ZTS Zoetis Inc.

Zoetis Delivers Strong Q2 2025 Results, Reaffirms Full-Year Outlook

Aug 05, 2025
ZTS Zoetis Inc.

Zoetis Inc. Dropped from Russell 1000 Dynamic Index

Jun 30, 2025
ZTS Zoetis Inc.

Stifel Downgrades Zoetis to Hold Amid Concerns Over Slower Growth and Competition

Jun 18, 2025
ZTS Zoetis Inc.

Zoetis Launches AI Masses for Vetscan Imagyst®, Enhancing AI-Powered Diagnostics

Jun 02, 2025
ZTS Zoetis Inc.

Dr. Mark Stetter Elected to Zoetis Board of Directors

May 21, 2025
ZTS Zoetis Inc.

Zoetis Strengthens U.S. Diagnostics Network with New Louisville Reference Laboratory

May 16, 2025
ZTS Zoetis Inc.

Zoetis Reports Strong Q1 2025 Results, Updates Full-Year Guidance

May 06, 2025
ZTS Zoetis Inc.

Zoetis Announces Positive Clinical Trial Results for Librela® in Canine OA Pain Management

Mar 25, 2025
ZTS Zoetis Inc.

Zoetis Receives USDA Conditional License for Avian Influenza Vaccine in Poultry

Feb 14, 2025
ZTS Zoetis Inc.

Zoetis Reports Strong 2024 Results, But 2025 Guidance Falls Below Estimates

Feb 13, 2025
ZTS Zoetis Inc.

Zoetis Updates U.S. Label for Canine Osteoarthritis Pain Treatment Librela®

Feb 04, 2025
ZTS Zoetis Inc.

Zoetis CEO Kristin Peck Reaffirms Safety of Arthritis Drug Librela for Dogs

Jan 14, 2025
ZTS Zoetis Inc.

FDA Issues Warning Regarding Zoetis's Dog Pain Drug Librela

Dec 17, 2024
ZTS Zoetis Inc.

Zoetis Board Approves 16% Increase in Quarterly Dividend for Q1 2025

Dec 12, 2024
ZTS Zoetis Inc.

Zoetis Unveils AI-Powered Vetscan OptiCell™ Hematology Analyzer

Dec 09, 2024
ZTS Zoetis Inc.

Zoetis Appoints Jamie Brannan as Chief Commercial Officer to Drive Global Growth

Nov 11, 2024
ZTS Zoetis Inc.

Zoetis Reports Strong Q3 2024 Results, Raises Full-Year Guidance

Nov 04, 2024
ZTS Zoetis Inc.

Zoetis Completes Divestiture of Medicated Feed Additive Portfolio

Oct 31, 2024
ICCC ImmuCell Corporation

ImmuCell Names Olivier te Boekhorst as President and CEO

Sep 29, 2025

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks